HappeningToo topic
Pioglitazone reports
Browse community reports connected to Pioglitazone. These reports can show that other people are describing similar experiences, but they do not prove that Pioglitazone caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
42 problems
Abdominal Discomfort while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and abdominal discomfort appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and abdominal distension appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and abdominal pain upper appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and abdominal pain appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and acid reflux appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and anxiety appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and back pain appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and constipation appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and cough appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and decreased appetite appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and dehydration appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and diarrhea appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and dizziness appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and dyspepsia appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and excessive sweating appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and fatigue appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and feeling abnormal appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and flushing appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and headache appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and hypotension appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and insomnia appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and itching appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and malaise appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and muscle spasms appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and muscular weakness appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and myalgia appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and nausea appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and pain appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and palpitations appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and peripheral swelling appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and rash appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and shortness of breath appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and skin redness appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and sleepiness appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and swelling appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and tingling or pins and needles appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and tremor appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and vision blurred appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and vomiting appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and weakness appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and weight decreased appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Pioglitazone
FDA FAERS contains adverse-event reports in which Pioglitazone and weight increased appear together. This does not establish that Pioglitazone caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →